Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Nucleic Acids Res ; 48(16): 9019-9036, 2020 09 18.
Article in English | MEDLINE | ID: mdl-32725242

ABSTRACT

Cilia assembly is under strict transcriptional control during animal development. In vertebrates, a hierarchy of transcription factors (TFs) are involved in controlling the specification, differentiation and function of multiciliated epithelia. RFX TFs play key functions in the control of ciliogenesis in animals. Whereas only one RFX factor regulates ciliogenesis in C. elegans, several distinct RFX factors have been implicated in this process in vertebrates. However, a clear understanding of the specific and redundant functions of different RFX factors in ciliated cells remains lacking. Using RNA-seq and ChIP-seq approaches we identified genes regulated directly and indirectly by RFX1, RFX2 and RFX3 in mouse ependymal cells. We show that these three TFs have both redundant and specific functions in ependymal cells. Whereas RFX1, RFX2 and RFX3 occupy many shared genomic loci, only RFX2 and RFX3 play a prominent and redundant function in the control of motile ciliogenesis in mice. Our results provide a valuable list of candidate ciliary genes. They also reveal stunning differences between compensatory processes operating in vivo and ex vivo.


Subject(s)
Cilia/physiology , Ependyma/cytology , Gene Expression Regulation, Developmental , Regulatory Factor X Transcription Factors/physiology , Regulatory Factor X1/physiology , Animals , Cilia/genetics , Mice , Mice, Inbred C57BL
2.
J Exp Med ; 213(2): 177-87, 2016 Feb 08.
Article in English | MEDLINE | ID: mdl-26809444

ABSTRACT

Evidence has recently emerged that butyrophilins, which are members of the extended B7 family of co-stimulatory molecules, have diverse functions in the immune system. We found that the human and mouse genes encoding butyrophilin-2A2 (BTN2A2) are regulated by the class II trans-activator and regulatory factor X, two transcription factors dedicated to major histocompatibility complex class II expression, suggesting a role in T cell immunity. To address this, we generated Btn2a2-deficient mice. Btn2a2(-/-) mice exhibited enhanced effector CD4(+) and CD8(+) T cell responses, impaired CD4(+) regulatory T cell induction, potentiated antitumor responses, and exacerbated experimental autoimmune encephalomyelitis. Altered immune responses were attributed to Btn2a2 deficiency in antigen-presenting cells rather than T cells or nonhematopoietic cells. These results provide the first genetic evidence that BTN2A2 is a co-inhibitory molecule that modulates T cell-mediated immunity.


Subject(s)
Genes, MHC Class II , Membrane Glycoproteins/genetics , Membrane Glycoproteins/immunology , Animals , Antigen-Presenting Cells/immunology , Butyrophilins , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Cancer Vaccines/immunology , Cell Line , DNA-Binding Proteins/genetics , DNA-Binding Proteins/immunology , Encephalomyelitis, Autoimmune, Experimental/genetics , Encephalomyelitis, Autoimmune, Experimental/immunology , Gene Expression Regulation , Humans , Immunity, Cellular , Membrane Glycoproteins/deficiency , Mice , Mice, Inbred C57BL , Mice, Knockout , Nuclear Proteins/genetics , Nuclear Proteins/immunology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Regulatory Factor X Transcription Factors , Trans-Activators/genetics , Trans-Activators/immunology , Transcription Factors/genetics , Transcription Factors/immunology
3.
Nat Commun ; 6: 8549, 2015 Oct 15.
Article in English | MEDLINE | ID: mdl-26469318

ABSTRACT

Sensorineural hearing loss is a common and currently irreversible disorder, because mammalian hair cells (HCs) do not regenerate and current stem cell and gene delivery protocols result only in immature HC-like cells. Importantly, although the transcriptional regulators of embryonic HC development have been described, little is known about the postnatal regulators of maturating HCs. Here we apply a cell type-specific functional genomic analysis to the transcriptomes of auditory and vestibular sensory epithelia from early postnatal mice. We identify RFX transcription factors as essential and evolutionarily conserved regulators of the HC-specific transcriptomes, and detect Rfx1,2,3,5 and 7 in the developing HCs. To understand the role of RFX in hearing, we generate Rfx1/3 conditional knockout mice. We show that these mice are deaf secondary to rapid loss of initially well-formed outer HCs. These data identify an essential role for RFX in hearing and survival of the terminally differentiating outer HCs.


Subject(s)
DNA-Binding Proteins/metabolism , Hair Cells, Auditory/metabolism , Hearing/physiology , Transcription Factors/metabolism , Animals , Animals, Newborn , Biological Evolution , Chromatin Immunoprecipitation , Female , Gene Expression Regulation , Hair Cells, Auditory/ultrastructure , Male , Mice, Inbred C57BL , Mice, Inbred ICR , Mice, Knockout , Multigene Family , Regulatory Factor X Transcription Factors , Regulatory Factor X1 , Sequence Analysis, DNA , Transcriptome , Zebrafish
4.
PLoS Genet ; 11(7): e1005368, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26162102

ABSTRACT

Spermatogenesis consists broadly of three phases: proliferation of diploid germ cells, meiosis, and finally extensive differentiation of the haploid cells into effective delivery vehicles for the paternal genome. Despite detailed characterization of many haploid developmental steps leading to sperm, only fragmentary information exists on the control of gene expression underlying these processes. Here we report that the RFX2 transcription factor is a master regulator of genes required for the haploid phase. A targeted mutation of Rfx2 was created in mice. Rfx2-/- mice are perfectly viable but show complete male sterility. Spermatogenesis appears to progress unperturbed through meiosis. However, haploid cells undergo a complete arrest in spermatid development just prior to spermatid elongation. Arrested cells show altered Golgi apparatus organization, leading to a deficit in the generation of a spreading acrosomal cap from proacrosomal vesicles. Arrested cells ultimately merge to form giant multinucleated cells released to the epididymis. Spermatids also completely fail to form the flagellar axoneme. RNA-Seq analysis and ChIP-Seq analysis identified 139 genes directly controlled by RFX2 during spermiogenesis. Gene ontology analysis revealed that genes required for cilium function are specifically enriched in down- and upregulated genes showing that RFX2 allows precise temporal expression of ciliary genes. Several genes required for cell adhesion and cytoskeleton remodeling are also downregulated. Comparison of RFX2-regulated genes with those controlled by other major transcriptional regulators of spermiogenesis showed that each controls independent gene sets. Altogether, these observations show that RFX2 plays a major and specific function in spermiogenesis.


Subject(s)
DNA-Binding Proteins/genetics , Infertility, Male/genetics , Spermatids/cytology , Spermatocytes/cytology , Spermatogenesis/genetics , Transcription Factors/genetics , Animals , Apoptosis/genetics , Cell Adhesion/genetics , Cilia/genetics , Cilia/physiology , Cyclic AMP Response Element Modulator/genetics , Cytoskeleton/genetics , Gene Expression Profiling , Gene Expression Regulation/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Regulatory Factor X Transcription Factors , Spermatogenesis/physiology , TATA-Binding Protein Associated Factors/genetics , Transcription Factor TFIID/genetics , Transcription, Genetic/genetics
5.
Nucleic Acids Res ; 42(15): 9641-55, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25104025

ABSTRACT

The activation, or maturation, of dendritic cells (DCs) is crucial for the initiation of adaptive T-cell mediated immune responses. Research on the molecular mechanisms implicated in DC maturation has focused primarily on inducible gene-expression events promoting the acquisition of new functions, such as cytokine production and enhanced T-cell-stimulatory capacity. In contrast, mechanisms that modulate DC function by inducing widespread gene-silencing remain poorly understood. Yet the termination of key functions is known to be critical for the function of activated DCs. Genome-wide analysis of activation-induced histone deacetylation, combined with genome-wide quantification of activation-induced silencing of nascent transcription, led us to identify a novel inducible transcriptional-repression pathway that makes major contributions to the DC-maturation process. This silencing response is a rapid primary event distinct from repression mechanisms known to operate at later stages of DC maturation. The repressed genes function in pivotal processes--including antigen-presentation, extracellular signal detection, intracellular signal transduction and lipid-mediator biosynthesis--underscoring the central contribution of the silencing mechanism to rapid reshaping of DC function. Interestingly, promoters of the repressed genes exhibit a surprisingly high frequency of PU.1-occupied sites, suggesting a novel role for this lineage-specific transcription factor in marking genes poised for inducible repression.


Subject(s)
Dendritic Cells/metabolism , Gene Silencing , Nuclear Proteins/genetics , Trans-Activators/genetics , Transcription, Genetic , Animals , Humans , Mice , Proto-Oncogene Proteins/metabolism , Trans-Activators/metabolism
6.
J Bone Miner Res ; 29(2): 290-303, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24038328

ABSTRACT

The molecular networks controlling bone homeostasis are not fully understood. The common evolution of bone and adaptive immunity encourages the investigation of shared regulatory circuits. MHC Class II Transactivator (CIITA) is a master transcriptional co-activator believed to be exclusively dedicated for antigen presentation. CIITA is expressed in osteoclast precursors, and its expression is accentuated in osteoporotic mice. We thus asked whether CIITA plays a role in bone biology. To this aim, we fully characterized the bone phenotype of two mouse models of CIITA overexpression, respectively systemic and restricted to the monocyte-osteoclast lineage. Both CIITA-overexpressing mouse models revealed severe spontaneous osteoporosis, as assessed by micro-computed tomography and histomorphometry, associated with increased osteoclast numbers and enhanced in vivo bone resorption, whereas osteoblast numbers and in vivo bone-forming activity were unaffected. To understand the underlying cellular and molecular bases, we investigated ex vivo the differentiation of mutant bone marrow monocytes into osteoclasts and immune effectors, as well as osteoclastogenic signaling pathways. CIITA-overexpressing monocytes differentiated normally into effector macrophages or dendritic cells but showed enhanced osteoclastogenesis, whereas CIITA ablation suppressed osteoclast differentiation. Increased c-fms and receptor activator of NF-κB (RANK) signaling underlay enhanced osteoclast differentiation from CIITA-overexpressing precursors. Moreover, by extending selected phenotypic and cellular analyses to additional genetic mouse models, namely MHC Class II deficient mice and a transgenic mouse line lacking a specific CIITA promoter and re-expressing CIITA in the thymus, we excluded MHC Class II expression and T cells from contributing to the observed skeletal phenotype. Altogether, our study provides compelling genetic evidence that CIITA, the molecular switch of antigen presentation, plays a novel, unexpected function in skeletal homeostasis, independent of MHC Class II expression and T cells, by exerting a selective and intrinsic control of osteoclast differentiation and bone resorption in vivo.


Subject(s)
Antigen Presentation/physiology , Cell Differentiation/immunology , Gene Expression Regulation/immunology , Nuclear Proteins/immunology , Osteoclasts/immunology , Receptor, Macrophage Colony-Stimulating Factor/immunology , Trans-Activators/immunology , Animals , Cell Differentiation/genetics , Gene Expression Regulation/genetics , Histocompatibility Antigens Class II/biosynthesis , Histocompatibility Antigens Class II/genetics , Histocompatibility Antigens Class II/immunology , Mice , Mice, Knockout , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Osteoclasts/cytology , Osteoclasts/metabolism , Receptor, Macrophage Colony-Stimulating Factor/genetics , Receptor, Macrophage Colony-Stimulating Factor/metabolism , T-Lymphocytes/cytology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Trans-Activators/genetics , Trans-Activators/metabolism
7.
Proc Natl Acad Sci U S A ; 106(8): 2735-40, 2009 Feb 24.
Article in English | MEDLINE | ID: mdl-19193853

ABSTRACT

In response to inflammatory stimulation, dendritic cells (DCs) have a remarkable pattern of differentiation (maturation) that exhibits specific mechanisms to control immunity. Here, we show that in response to Lipopolysaccharides (LPS), several microRNAs (miRNAs) are regulated in human monocyte-derived dendritic cells. Among these miRNAs, miR-155 is highly up-regulated during maturation. Using LNA silencing combined to microarray technology, we have identified the Toll-like receptor/interleukin-1 (TLR/IL-1) inflammatory pathway as a general target of miR-155. We further demonstrate that miR-155 directly controls the level of TAB2, an important signal transduction molecule. Our observations suggest, therefore, that in mature human DCs, miR-155 is part of a negative feedback loop, which down-modulates inflammatory cytokine production in response to microbial stimuli.


Subject(s)
Dendritic Cells/metabolism , Interleukin-1/metabolism , MicroRNAs/physiology , Monocytes/metabolism , Signal Transduction/physiology , Adaptor Proteins, Signal Transducing/genetics , Adaptor Proteins, Signal Transducing/metabolism , Base Sequence , Cells, Cultured , DNA Primers , Humans , Lymphocyte Activation , RNA Processing, Post-Transcriptional , Toll-Like Receptors/metabolism
8.
Diabetes ; 56(4): 950-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17229940

ABSTRACT

The transcription factor regulatory factor X (RFX)-3 regulates the expression of genes required for the growth and function of cilia. We show here that mouse RFX3 is expressed in developing and mature pancreatic endocrine cells during embryogenesis and in adults. RFX3 expression already is evident in early Ngn3-positive progenitors and is maintained in all major pancreatic endocrine cell lineages throughout their development. Primary cilia of hitherto unknown function present on these cells consequently are reduced in number and severely stunted in Rfx3(-/-) mice. This ciliary abnormality is associated with a developmental defect leading to a uniquely altered cellular composition of the islets of Langerhans. Just before birth, Rfx3(-/-) islets contain considerably less insulin-, glucagon-, and ghrelin-producing cells, whereas pancreatic polypeptide-positive cells are markedly increased in number. In adult mice, the defect leads to small and disorganized islets, reduced insulin production, and impaired glucose tolerance. These findings suggest that RFX3 participates in the mechanisms that govern pancreatic endocrine cell differentiation and that the presence of primary cilia on islet cells may play a key role in this process.


Subject(s)
DNA-Binding Proteins/physiology , Islets of Langerhans/physiology , Transcription Factors/physiology , Animals , Cilia/physiology , Cilia/ultrastructure , Crosses, Genetic , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/genetics , Female , Ghrelin , Glucose Tolerance Test , Islets of Langerhans/cytology , Mice , Mice, Knockout , Peptide Hormones/analysis , Pregnancy , RNA, Messenger/genetics , Regulatory Factor X Transcription Factors , Reverse Transcriptase Polymerase Chain Reaction , Stem Cells/cytology , Stem Cells/physiology , TATA-Box Binding Protein/genetics , Transcription Factors/deficiency , Transcription Factors/genetics
9.
Nucleic Acids Res ; 35(2): 595-605, 2007.
Article in English | MEDLINE | ID: mdl-17175541

ABSTRACT

The small GTPase RAB4 regulates endocytic recycling, a process that contributes to Major Histocompatibility Complex (MHC)-mediated antigen presentation by specialized antigen presenting cells (APC) of the immune system. The gene encoding the RAB4B isoform of RAB4 was singled out by two complementary genome-wide screens. One of these consisted of a computer scan to identify genes containing characteristic MHC class II-related regulatory sequences. The second was the use of chromatin immunoprecipitation coupled to microarrays (ChIP-on-chip) to identify novel targets of a transcriptional co-activator called the MHC class II transactivator (CIITA). We show that the RAB4B gene is regulated by a typical MHC class II-like enhancer that is controlled directly by both CIITA and the multiprotein transcription factor complex known as the MHC class II enhanceosome. RAB4B expression is thus activated by the same regulatory machinery that is known to be essential for the expression of MHC class II genes. This molecular link between the transcriptional activation of RAB4B and MHC class II genes implies that APC boost their antigen presentation capacity by increasing RAB4-mediated endocytic recycling.


Subject(s)
Enhancer Elements, Genetic , Genes, MHC Class II , Transcriptional Activation , rab4 GTP-Binding Proteins/genetics , Binding Sites , Cells, Cultured , DNA-Binding Proteins , Dendritic Cells/immunology , Endocytosis , Genomics , Humans , Interferon-gamma/pharmacology , Nuclear Proteins/metabolism , Promoter Regions, Genetic , Regulatory Factor X Transcription Factors , Trans-Activators/metabolism , Transcription Factors , rab4 GTP-Binding Proteins/biosynthesis
10.
Eur J Immunol ; 36(6): 1548-58, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16703565

ABSTRACT

CIITA is a master regulatory factor for the expression of MHC class II (MHC-II) and accessory genes involved in Ag presentation. It has recently been suggested that CIITA also regulates numerous other genes having diverse functions within and outside the immune system. To determine whether these genes are indeed relevant targets of CIITA in vivo, we studied their expression in CIITA-transgenic and CIITA-deficient mice. In contrast to the decisive control of MHC-II and related genes by CIITA, nine putative non-MHC target genes (Eif3s2, Kpna6, Tap1, Yars, Col1a2, Ctse, Ptprr, Tnfsf6 and Plxna1) were found to be CIITA independent in all cell types examined. Two other target genes, encoding IL-4 and IFN-gamma, were indeed found to be up- and down-regulated, respectively, in CIITA-transgenic CD4(+) T cells. However, there was no correlation between MHC-II expression and this Th2 bias at the level of individual transgenic T cells, indicating an indirect control by CIITA. These results show that MHC-II-restricted Ag presentation, and its indirect influences on T cells, remains the only pathway under direct control by CIITA in vivo. They also imply that precisely regulated MHC-II expression is essential for maintaining a proper Th1-Th2 balance.


Subject(s)
Histocompatibility Antigens Class II/genetics , Nuclear Proteins/genetics , Trans-Activators/genetics , Animals , Female , Flow Cytometry , Gene Expression Regulation/genetics , Gene Expression Regulation/immunology , Histocompatibility Antigens Class II/biosynthesis , Histocompatibility Antigens Class II/immunology , Interferon-gamma/biosynthesis , Interferon-gamma/genetics , Interleukin-4/biosynthesis , Interleukin-4/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Knockout , Mice, Transgenic , Nuclear Proteins/biosynthesis , Nuclear Proteins/immunology , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Substrate Specificity , Th1 Cells/immunology , Th2 Cells/immunology , Trans-Activators/biosynthesis , Trans-Activators/immunology
11.
Mol Cell Biol ; 25(19): 8607-18, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16166641

ABSTRACT

The transcription factors RFX and CIITA are major players in regulation of the expression of all classical and nonclassical major histocompatibility complex class II (MHC-II) genes. RFX nucleates the formation of a multiprotein complex, called the MHC-II enhanceosome, on MHC-II promoters. Assembly of this enhanceosome is an obligatory step for recruitment of the coactivator CIITA and thus for activation of MHC-II gene transcription. We have analyzed the function of the ankyrin repeat-containing protein RFXANK, which forms the heterotrimeric RFX complex together with RFX5 and RFXAP. We discovered that ANKRA2, the closest paralogue of RFXANK, can substitute for RFXANK in the activation of MHC-II genes and that this ability is mediated by its ankyrin repeat domain (ARD). This finding provided the basis for a high-resolution structure-function analysis of the ARD of RFXANK, which allowed us to map the RFX5 interaction domain and residues critical for assembly of the RFX complex. We also found that mutations in the fourth ankyrin repeat of RFXANK abolish assembly of the enhanceosome on MHC-II promoters in vivo but not in vitro, suggesting a new role of RFXANK in facilitating promoter occupation in the context of chromatin.


Subject(s)
Histocompatibility Antigens Class II , Mutagenesis , Transcription Factors/genetics , Transcription Factors/physiology , Amino Acid Sequence , Cell Line , Cell Separation , Chromatin/metabolism , Chromatin Immunoprecipitation , DNA-Binding Proteins , Flow Cytometry , Glutathione Transferase/metabolism , Humans , Immunoprecipitation , Models, Molecular , Molecular Sequence Data , Mutation , Nuclear Proteins/chemistry , Plasmids/metabolism , Promoter Regions, Genetic , Protein Binding , Protein Biosynthesis , Protein Conformation , Protein Structure, Secondary , Protein Structure, Tertiary , RNA, Messenger/metabolism , Recombinant Fusion Proteins/chemistry , Sequence Homology, Amino Acid , Trans-Activators/chemistry , Transcription Factors/metabolism , Transcription, Genetic
12.
J Immunol ; 173(10): 6200-10, 2004 Nov 15.
Article in English | MEDLINE | ID: mdl-15528357

ABSTRACT

MHC class II (MHC-II) genes are regulated by an enhanceosome complex containing two gene-specific transcription factors, regulatory factor X complex (RFX) and CIITA. These factors assemble on a strictly conserved regulatory module (S-X-X2-Y) found immediately upstream of the promoters of all classical and nonclassical MHC-II genes as well as the invariant chain (Ii) gene. To identify new targets of RFX and CIITA, we developed a computational approach based on the unique and highly constrained architecture of the composite S-Y motif. We identified six novel S'-Y' modules situated far away from the promoters of known human RFX- and CIITA-controlled genes. Four are situated at strategic positions within the MHC-II locus, and two are found within the Ii gene. These S'-Y' modules function as transcriptional enhancers, are bona fide targets of RFX and CIITA in B cells and IFN-gamma-induced cells, and induce broad domains of histone hyperacetylation. These results reveal a hitherto unexpected level of complexity involving long distance control of MHC-II expression by multiple distal regulatory elements.


Subject(s)
DNA-Binding Proteins/physiology , Enhancer Elements, Genetic/physiology , Gene Expression Profiling , Genes, MHC Class II , Locus Control Region/physiology , Nuclear Proteins/physiology , Trans-Activators/physiology , Transcription Factors/physiology , Acetylation , Acetyltransferases/metabolism , Antigens, Differentiation, B-Lymphocyte/genetics , Antigens, Differentiation, B-Lymphocyte/metabolism , Base Sequence , Cell Line, Tumor , Computational Biology/methods , Conserved Sequence , DNA-Binding Proteins/metabolism , Gene Expression Profiling/methods , Genetic Markers/immunology , Histocompatibility Antigens Class II/genetics , Histocompatibility Antigens Class II/metabolism , Histone Acetyltransferases , Histones/metabolism , Humans , Interferon-gamma/physiology , Molecular Sequence Data , Nuclear Proteins/metabolism , Promoter Regions, Genetic , Protein Binding/genetics , Protein Binding/immunology , Regulatory Factor X Transcription Factors , Trans-Activators/metabolism , Transcription Factors/metabolism
13.
Nat Immunol ; 4(2): 132-7, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12524537

ABSTRACT

In vivo, a wild-type pattern of major histocompatibility complex (MHC) class II expression requires a locus control region (LCR). Whereas the role of promoter-proximal MHC class II regulatory sequences is well established, the function of the distal LCR remained obscure. We show here that this LCR is bound by the MHC class II-specific transactivators regulatory factor X (RFX) and class II transactivator (CIITA). Binding of these factors induces long-range histone acetylation, RNA polymerase II recruitment and the synthesis of extragenic transcripts within the LCR. The finding that RFX and CIITA regulate the function of the MHC class II LCR reveals an unexpected degree of complexity in the mechanisms controlling MHC class II gene expression.


Subject(s)
Chromatin/genetics , Genes, MHC Class II , Locus Control Region , Nuclear Proteins , Animals , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Binding Sites/genetics , Cell Line , Chromatin/metabolism , DNA-Binding Proteins/metabolism , Enhancer Elements, Genetic , Gene Expression Regulation , HLA-DR Antigens/genetics , HLA-DR alpha-Chains , Humans , Mice , RNA Polymerase II/metabolism , Regulatory Factor X Transcription Factors , Trans-Activators/metabolism , Transcription Factors/metabolism , Transcription, Genetic
14.
Mol Ther ; 6(6): 824-9, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12498778

ABSTRACT

Major histocompatibility complex class II (MHCII) deficiency is a primary immunodeficiency resulting from defects in one of four different MHCII-specific transcription factors-CIITA, RFX5, RFXAP, and RFXANK. Despite this genetic heterogeneity, the phenotypical manifestations are homogeneous. It is frequently difficult to establish a definitive diagnosis of the disease on the basis of clinical and immunological criteria. Moreover, the phenotypical homogeneity precludes unambiguous identification of the regulatory gene that is affected. Identification of the four genes mutated in the disease has now allowed us to develop a rapid and straightforward diagnostic test for new MHCII-deficiency patients. This test is based on direct correction of the genetic defect by transduction of cells from patients with lentiviral vectors encoding CIITA, RFXANK, RFX5, or RFXAP. We have validated this approach by defining the molecular defects in two new patients. The RFXANK vector restored MHCII expression in a T cell line from one patient. The RFXAP vector corrected primary cells (PBL) from a second patient. Molecular analysis confirmed the presence of homozygous mutations in the RFXANK and RFXAP genes, respectively. Direct genetic correction represents a valuable tool for the diagnosis and classification of new MHCII-deficiency patients.


Subject(s)
DNA-Binding Proteins/genetics , Histocompatibility Antigens Class II/analysis , Immunologic Deficiency Syndromes/diagnosis , Immunologic Deficiency Syndromes/genetics , Nuclear Proteins , Trans-Activators/genetics , Transcription Factors/genetics , Amino Acid Sequence , Base Sequence , Cell Line , DNA-Binding Proteins/metabolism , Female , Genetic Complementation Test , Genetic Therapy , Genetic Vectors/genetics , Histocompatibility Antigens Class II/genetics , Humans , Immunologic Deficiency Syndromes/classification , Immunologic Deficiency Syndromes/pathology , Lentivirus/genetics , Male , Molecular Sequence Data , Regulatory Factor X Transcription Factors , Reproducibility of Results , T-Lymphocytes/metabolism , Trans-Activators/metabolism , Transcription Factors/metabolism , Transduction, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...